Edward M. Kaye M.D. is Director at Stoke Therapeutics, Inc. (STOK). They have made 22 open-market trades across 3 companies since 2015, most recently 2026-08-18.
CIK 0001522780
1 open-market purchase totalling $9K since 2015, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| STOK | 124,557 | $3.0M |
| SRPT | 87,932 | $1.5M |
| CYTK | 10,434 | $647K |
| RNA | 6,692 | $51K |
| Total | $5.2M |
Shares reported on the most recent Form 4, priced at the 2026-08-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| STOK | SELL | 2026-08-18 | 2026-08-18 | $32.03 | $403K | -3.5% | -11.7% | — |
| CYTK | SELL | 2026-06-01 | 2026-06-01 | $76.09 | $223K | -5.4% | +16.4% | -3.2% |
| STOK | SELL · 10b5-1 | 2025-12-08 | 2025-12-10 | $32.37 | $702K | -1.0% | -2.9% | +13.3% |
| STOK | SELL · 10b5-1 | 2025-12-04 | 2025-12-05 | $31.11 | $879K | +5.0% | +4.0% | +10.8% |
| STOK | SELL | 2025-12-02 | 2025-12-03 | $30.22 | $65K | +9.1% | +2.2% | +11.7% |
| CYTK | SELL | 2025-12-01 | 2025-12-02 | $66.72 | $3.7M | -0.5% | -3.1% | -3.5% |
| CYTK | SELL · 10b5-1 | 2025-11-11 | 2025-11-12 | $65.08 | $337K | +3.0% | -3.0% | -0.7% |
| STOK | SELL · 10b5-1 | 2025-10-08 | 2025-10-10 | $30.00 | $750K | +7.8% | -25.9% | +11.6% |
| CYTK | SELL · 10b5-1 | 2025-10-06 | 2025-10-06 | $60.00 | $405K | -2.6% | -2.3% | +1.2% |
| STOK | SELL · 10b5-1 | 2025-10-03 | 2025-10-07 | $25.09 | $2.1M | +22.2% | -18.1% | +18.6% |
| CYTK | SELL | 2025-09-30 | 2025-09-30 | $55.08 | $738K | +8.9% | +12.9% | +12.0% |
| CYTK | SELL · 10b5-1 | 2025-09-02 | 2025-09-02 | $50.00 | $338K | +2.5% | +12.9% | +32.4% |
| STOK | SELL · 10b5-1 | 2025-08-29 | 2025-09-03 | $20.13 | $2.5M | +18.6% | +29.5% | +51.1% |
| STOK | SELL | 2025-08-18 | 2025-08-20 | $18.24 | $442K | +1.7% | +18.9% | +50.2% |
| CYTK | SELL | 2025-06-05 | 2025-06-05 | $32.10 | $233K | +0.8% | +3.3% | +54.9% |
| STOK | SELL | 2025-03-18 | 2025-03-20 | $8.49 | $327K | -24.1% | +4.9% | +40.9% |
| STOK | SELL | 2024-12-09 | 2024-12-11 | $12.99 | $176K | -9.6% | -30.0% | -36.2% |
| STOK | SELL | 2024-12-06 | 2024-12-10 | $12.78 | $158K | -11.8% | -32.1% | -40.0% |
| STOK | SELL · 10b5-1 | 2024-05-20 | 2024-05-22 | $15.41 | $1.3M | +2.4% | -8.4% | -5.3% |
| STOK | SELL | 2024-03-19 | 2024-03-19 | $6.10 | $68K | +131.8% | +100.2% | +168.0% |
| CYTK | SELL | 2022-08-05 | 2022-08-08 | $50.00 | $571K | -3.4% | -3.0% | -30.5% |
| CYTK | SELL | 2021-12-23 | 2021-12-23 | $45.00 | $675K | -11.6% | -29.4% | -16.6% |
| STOK | SELL | 2020-12-17 | 2020-12-18 | $60.00 | $1.5M | +4.9% | +18.2% | -20.9% |
| STOK | SELL | 2020-11-27 | 2020-11-30 | $50.00 | $608K | -1.2% | +14.1% | +16.2% |
| STOK | SELL | 2020-11-25 | 2020-11-25 | $50.00 | $642K | +4.9% | +23.7% | +20.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.